| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Cumulex N.V. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.81 |
| 52 Week High | €2.20 |
| 52 Week Low | €0.81 |
| Beta | -0.96 |
| 11 Month Change | -40.00% |
| 3 Month Change | -40.00% |
| 1 Year Change | -63.84% |
| 33 Year Change | -56.22% |
| 5 Year Change | -59.90% |
| Change since IPO | -88.77% |
Recent News & Updates
Recent updates
Shareholder Returns
| CLEX | BE Food | BE Market | |
|---|---|---|---|
| 7D | 0% | -1.0% | 0.2% |
| 1Y | -63.8% | 41.7% | 5.9% |
Return vs Industry: CLEX underperformed the Belgian Food industry which returned 41.7% over the past year.
Return vs Market: CLEX underperformed the Belgian Market which returned 5.9% over the past year.
Price Volatility
| CLEX volatility | |
|---|---|
| CLEX Average Weekly Movement | 14.7% |
| Food Industry Average Movement | 4.0% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in BE Market | 7.3% |
| 10% least volatile stocks in BE Market | 2.3% |
Stable Share Price: CLEX's share price has been volatile over the past 3 months.
Volatility Over Time: CLEX's weekly volatility has decreased from 21% to 15% over the past year, but is still higher than 75% of Belgian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1956 | n/a | Gerben Hettinga | www.cumulex.be |
Cumulex N.V. does not have significant operations. Previously, the company was engaged in sugar plantation business in the Democratic Republic of Congo. The company was formerly known as Sucrerie et Raffinerie de l'Afrique Centrale NV and changed its name to Cumulex N.V. in March 2021.
Cumulex N.V. Fundamentals Summary
| CLEX fundamental statistics | |
|---|---|
| Market cap | €356.40k |
| Earnings (TTM) | -€75.91k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-4.7x
P/E RatioIs CLEX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CLEX income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €75.91k |
| Gross Profit | -€75.91k |
| Other Expenses | €0 |
| Earnings | -€75.91k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.17 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did CLEX perform over the long term?
See historical performance and comparison